TEPYLUTE

Formula & Concentration

TEPYLUTE – thiotepa 10 mg/mL intravenous solution

Manufacturer

Shorla Oncology Inc.

Indications

Pericardial malignant effusion; pleural malignant effusion; malignant tumor of urinary bladder; malignant neoplasm of the ovary; malignant ascites; conditioning prior to allogeneic stem cell transplant; conditioning prior to autologous stem cell transplant; carcinoma of breast; malignancy

Product Options

Package Size

NDC #

Presentation

15 mg/1.5 mL

81927-0105-01

Vial

100 mg/10 mL

81927-0106-01

Vial

Shelf Life and Storage

Fridge (2-8°C)